dongmei shi | Immunology | Global Impact in Research Award

Posted on by sciencefather

Dr. Dongmei shi | Immunology | Global Impact in Research Award

Dr. Dongmei shi, Jining NO.1 peoples’ hospital, China.

Dr. Dongmei Shi 🧪 is a Professor of Dermatology at Jining No.1 People’s Hospital, specializing in medical mycology 🦠 and infection immunology 🛡️. She has discovered new fungal species, revealed immune evasion pathways, and developed innovative diagnostic tools 🔬. A leader in clinical and translational research, Dr. Shi has led several nationally funded projects 🇨🇳 and serves on prestigious medical committees 👩‍⚕️. Her work significantly advances skin infection treatment and global dermatological science 🌍.

🌟 Professional Profile

Scopus profile

🎓 Early Academic Pursuits

Dr. Dongmei Shi earned her doctoral degree in Dermatology and Venereology from the esteemed Fourth Military Medical University. Her academic foundation was built on rigorous training and a commitment to deepening her understanding of skin disorders and infections. From the outset, she demonstrated a keen interest in medical mycology and infection immunology, which laid the groundwork for her future innovations and research contributions.

💼 Professional Endeavors

Currently serving as a Professor in the Department of Dermatology and the Medical Mycology Laboratory at Jining NO.1 People’s Hospital, Dr. Shi has built an impressive career. With years of clinical experience, she excels in diagnosing and treating a wide range of skin diseases. Her work merges clinical acumen with scientific inquiry, making her a pivotal figure in integrating patient care with research-driven solutions.

🔬 Contributions and Research Focus On Immunology 

Dr. Shi’s research spans the taxonomy of medical fungi, the pathogenicity of fungal infections, and the immune responses triggered by skin pathogens. She has discovered novel fungal species and immune evasion pathways that pave the way for targeted antifungal drug development. Her innovation extends to clinical technologies, including a rapid fungal detection kit and novel treatment strategies using phototherapy and biologics, improving diagnostic precision and therapeutic outcomes.

🌍 Impact and Influence

Her findings have redefined aspects of fungal taxonomy and infection immunology, directly impacting clinical practices and theoretical knowledge in dermatology. Through her projects funded by the National Natural Science Foundation of China and provincial bodies, she has created platforms for translational research, driving both academic progress and patient care. Her rapid diagnostic tools and immunotherapy strategies are increasingly recognized in the medical community.

🏆 Awards and Honors

Dr. Shi’s leadership and scholarly impact have earned her positions in multiple prestigious organizations. She is a Council Member of the Asia-Pacific Medical Mycology Society, Editorial Board Member of the Chinese Journal of Mycology, and Executive Committee Member in various national dermatological and medical mycology societies. These roles recognize her excellence and her influential voice in shaping dermatological science.

📊Academic Citations

Dr. Shi has published numerous high-quality papers in top-tier dermatological and mycological journals, significantly contributing to the body of literature in her field. Her work on Candidalysin pathways, dendritic cell modulation, and immune response mechanics is frequently cited by peers, reflecting the global relevance and scientific rigor of her research.

🚀 Legacy and Future Contributions

Dr. Dongmei Shi stands as a beacon of innovation in dermatology, bridging research, clinical practice, and technology. Her future work aims to further unravel the complex interplay between fungal pathogens and immune responses, explore personalized immunotherapy, and advance standardization in dermatological diagnostics. As she continues to lead groundbreaking studies and mentor emerging scholars, her legacy is set to inspire generations of medical professionals. 🌱

📚Publications Top Notes

1️⃣ Photodynamic therapy combined with palliative resection and secondary healing for periocular basal cell carcinoma with inadequate surgical margins

👩‍⚕️ Authors: X. Wang, T. Zhang, T. Li, Y. Song, D. Shi, Dongmei
🗓️ Journal: Photodiagnosis and Photodynamic Therapy
📅 Year: 2025
🔬 Type: Article

2️⃣ Successful management of recurrent cutaneous granulomas caused by Candida albicans using aminolevulinic acid photodynamic therapy post-surgery: A case report

👩‍⚕️ Authors: L. Wang, Y. Feng, S. Wang, Z. Yang, D. Shi, Dongmei
🗓️ Journal: Photodiagnosis and Photodynamic Therapy
📅 Year: 2025
📝 Type: Case Report

3️⃣ Immunoglobulin E, the potential accelerator of comorbid psoriasis and atherosclerosis

👩‍⚕️ Authors: Y. Wang, D. Li, Z. Yan, D. Shi, Dongmei
🔢 Citations: 1
🧪 Type: Review

4️⃣ Fungal influence on immune cells and inflammatory responses in the tumor microenvironment (Review)

👩‍⚕️ Authors: J. Zhang, Y. Feng, D. Li, D. Shi, Dongmei
🧬 Type: Review

5️⃣ Decoding the enigmatic role of T-cadherin in tumor angiogenesis

👩‍⚕️ Authors: H. Xiong, D. Shi, Dongmei
🧠 Type: Review

6️⃣ Cardiovascular comorbidities among patients with psoriasis: a national register-based study in China

👩‍⚕️ Authors: P. Cui, D. Li, L. Shi, R. Li, D. Shi, Dongmei
🗓️ Journal: Scientific Reports
📅 Year: 2024
🔢 Citations: 2
📊 Type: Article

7️⃣ Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates

👩‍⚕️ Authors: D. Shi, Dongmei, Z. Yang, W. Liao, S. de Hoog, S. Deng
🗓️ Journal: IMA Fungus
📅 Year: 2024
🔢 Citations: 2
🧫 Type: Article

8️⃣ Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition)

👩‍⚕️ Authors: G. Liang, X. Li, R. Li, X. Kong, W. Liu
🗓️ Journal: Mycoses
📅 Year: 2024
📜 Type: Consensus Statement

Agustina Costa | Immunology and Microbiology | Best Researcher Award

Posted on by sciencefather

Dr. Agustina Costa | Immunology and Microbiology | Best Researcher Award

Dr. Agustina Costa, Anlis-Malbran, Argentina.

Agustina Costa is a highly accomplished biologist and researcher specializing in microbiology and biochemistry. She earned her PhD in Pharmacy and Biochemistry from the University of Buenos Aires in 2023, where she achieved an outstanding grade for her thesis focused on detecting β-lactamases in Enterobacterales using MALDI-TOF mass spectrometry. Agustina also holds a Licenciatura in Biological Sciences from Universidad Favaloro and has over 17 years of professional experience in renowned institutions like INEI-ANLIS-MALBRAN and Hospital Alemán. Her research expertise is showcased in numerous high-impact publications, particularly in the fields of microbial diagnostics and antimicrobial resistance. She has presented her findings at over 15 national and international conferences and has contributed to various research projects funded by ANPCyT and CONICET. Fluent in English and skilled in advanced genomic analysis, Agustina is dedicated to advancing the field of microbiology and improving public health through innovative research.

Professional Profile:

Scopus

Summary of Suitability for Best Researcher Award

Agustina Costa, PhD in Pharmacy and Biochemistry from the University of Buenos Aires, demonstrates exceptional expertise in microbiology with a specialized focus on using MALDI-TOF MS for the rapid detection of β-lactamase-producing Enterobacterales. Her academic background, complemented by a Licenciatura in Biological Sciences, reflects a strong foundation in microbial research and diagnostic methodologies. Throughout her career, she has been affiliated with prestigious institutions, including INEI-ANLIS-MALBRAN and Hospital Alemán, where she honed her skills in microbiology and molecular biology.

🎓 Education:

Agustina Costa has a strong academic foundation, highlighted by a PhD in Pharmacy and Biochemistry from the University of Buenos Aires (2023), where she achieved an “Outstanding” grade for her thesis on β-lactamase detection using MALDI-TOF mass spectrometry. Her academic journey began with a Licenciatura in Biological Sciences from Universidad Favaloro, complemented by technical training in microbiology. This blend of theoretical knowledge and practical skills demonstrates her commitment to scientific excellence and specialized expertise in microbiology and biochemistry

💼Professional Experience:

Agustina Costa has over 17 years of diverse experience in microbiology, working in prominent institutions such as INEI-ANLIS-MALBRAN and Hospital Alemán. Currently, she serves as a professional in the Enterobacteria Service, showcasing her hands-on expertise in microbiological research and diagnostics. Her previous roles span from molecular biology techniques to quality control in microbiology, reflecting her comprehensive knowledge in clinical and laboratory settings

🌍 Publications and Research Contributions

Agustina Costa has an impressive portfolio of publications, including multiple research articles in high-impact journals such as Pathogens, Frontiers in Cellular and Infection Microbiology, and Journal of Microbiological Methods. Her work primarily focuses on the use of MALDI-TOF MS for rapid microbial identification and antimicrobial resistance detection, highlighting her contributions to advancing diagnostic microbiology. Notably, her research on KPC detection and the genomic characterization of resistant plasmids demonstrates her commitment to addressing critical challenges in public health.

🥇Award and Honors:

Agustina Costa has been recognized for her exceptional contributions to microbiology and biochemistry through multiple awards and honors. She has presented her groundbreaking research at over 15 prestigious national and international conferences, including ASM Microbe, SADI-Argentina, and SADEBAC-Argentina, where she often served as the first author. Agustina has also secured competitive research grants from ANPCyT and CONICET, reflecting her ability to lead impactful scientific projects. Her innovative work in microbial diagnostics, particularly in using MALDI-TOF MS for rapid pathogen detection, has earned her accolades within the scientific community, solidifying her reputation as a leader in the field of microbiology.

Conclusion:

Agustina Costa stands out as a highly skilled researcher with a robust background in microbiology and biochemistry. Her extensive academic achievements, highlighted by a PhD with distinction from the University of Buenos Aires, are complemented by over 17 years of professional experience in prominent research institutions. Agustina’s impressive portfolio of high-impact publications, particularly in antimicrobial resistance and microbial diagnostics using MALDI-TOF MS, demonstrates her expertise and contributions to public health. Her active engagement in scientific conferences and successful grant applications further solidify her reputation as a leading researcher. Overall, Agustina’s dedication and accomplishments make her a strong contender for the Research for Best Researcher

📖 Publication Top Notes

  1. MALDI-TOF MS-Based KPC Direct Detection from Patients’ Positive Blood Culture Bottles, Short-Term Cultures, and Colonies at the Hospital | 3 citations 📊

  2. Co-Occurrence of NDM-5 and RmtB in a Clinical Isolate of Escherichia coli Belonging to CC354 in Latin America | 12 citations 📊

  3. Bacteremia and Sepsis by Arcanobacterium haemolyticum in a Young Immunocompetent Patient| 4 citations 📊

  4. MALDI-TOF MS Based Procedure to Detect KPC-2 Directly from Positive Blood Culture Bottles and Colonies |33 citations 📊